Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02525783 · ClinicalTrials.gov registry record
Aequalis Pyrocarbon IDE; Replacing the Humeral Head in Hemi-Arthroplasty
A clinical trial, sponsored by Stryker Trauma and Extremities.
- Completed
- Registry status
- 157
- Enrollment target
NCT02525783: Completed study, sponsored by Stryker Trauma and Extremities.
NCT02525783 is a clinical trial that has completed, run by Stryker Trauma and Extremities. The registered enrollment target is 157 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02525783 has completed, sponsored by Stryker Trauma and Extremities.
- COMPLETED
- Registry status
- 157 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate safety and effectiveness of the Aequalis Pyrocarbon Humeral Head in hemiarthroplasty at 24 months.
Primary Outcome
A subject is a success at 24 months if: * Their change in Constant score is greater than or equal to 17 and * They did not have revision surgery; and * There is no radiographic evidence of system disassembly or fracture, and * They did not have a system-related serious adverse event.
Interventions
- DEVICE Aequalis Pyrocarbon Humeral Head
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2015-12 |
| Est. Completion | 2022-10-07 |
What the finished NCT02525783 record still lists
NCT02525783 is an interventional study that assigns participants to a tested intervention. The registered 157 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Aequalis Pyrocarbon Humeral Head is the first listed.
NCT02525783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02525783 about?
NCT02525783 is a clinical study titled "Aequalis Pyrocarbon IDE; Replacing the Humeral Head in Hemi-Arthroplasty". The purpose of this study is to demonstrate safety and effectiveness of the Aequalis Pyrocarbon Humeral Head in hemiarthroplasty at 24 months.
What is the current status of trial NCT02525783?
This trial is currently completed. The enrollment target is 157 participants. The study started on 2015-12. Estimated completion is 2022-10-07.
What interventions are being tested in trial NCT02525783?
The interventions under investigation include: Aequalis Pyrocarbon Humeral Head (DEVICE).
Who is sponsoring clinical trial NCT02525783?
This trial is sponsored by Stryker Trauma and Extremities, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05052541 · 157 participants · Phase 3
Safety and Efficacy of Oral Cannabis in Chronic Spine Pain
- NCT05076942 · 157 participants · Phase 2
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
- NCT06396598 · 157 participants · NA
Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer
- NCT06655246 · 157 participants · Phase 1
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia